SGHT Company Profile and Key Details

Sight Sciences, Inc. (NASDAQ:SGHT) closed at $8.08 USD, losing -$0.06 (-0.74%) from the previous close of $8.14. The stock is currently mid-range between its 52-week high and low $3.19 and $9.24. With a market capitalization of about $439.63 million, Sight Sciences, Inc. is classified as a small-cap and shows higher-than-market volatility (beta ~2.50). Key stats such as the average daily volume over the past year has been around 225.98 thousand shares, in line with its 52-week average. Headquartered in Menlo Park, CA, Sight Sciences, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Paul Badawi, the company employs approximately 186 people and listed since July 15, 2021. Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases.

Short-term trend indicators are mixed aligned (SMA20 -6.34%, SMA50 -20.99%, SMA200 4.96%). The stock’s 14-day RSI is 35.22 (weak momentum), while the ATR of 0.34 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -42.4% below its high and over 162.07% above its low. Average 10-day trading volume of 157.53 thousand shares is below the 3-month average of 218.59 thousand, indicating normal recent market interest.

Sight Sciences, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $2.26. This means the shares are trading above this model’s fair value.

Sight Sciences, Inc. generated EPS of -$0.90 over the past year. Five-year average earnings growth is -13.18%. Wall Street analysts project EPS growth of 24.66% annually over the next five years. The latest quarter delivered EPS of -$0.08. The next quarter is forecast at -$0.15. Next year's EPS is expected at $8.20. Analyst sentiment is neutral. Analyst rating data shows there are 1 Strong Buy ratings, 6 Buy ratings, 8 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $12.00 to $4.00. The high target offers 48.51% upside. The low target suggests -50.5% downside. The mean target is $7.96. This offers -1.49% upside. Sight Sciences, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended August 05, 2026, missed forecasts by -56.36%. The prior quarter beat by 26.32%. Over the last six quarters, Apple has recorded several small beats. These include -3.45% in May 08, 2025.

Sight Sciences, Inc. has 55.09 million shares outstanding. The public float is 35.59 million shares, elevated short interest at 2.06% of float. This equals 826.71 thousand shares. The short ratio is 5.27 days. Institutional investors hold 65.55% of the float. Insiders own 20.06%. Badawi Paul holds 6.12 million shares, D1 Capital Partners L.P. has 3.00 million shares and Badawi David has 1.98 million shares. Over the past six months, insider transactions show net selling. They sold 182.62 thousand shares across 13 transactions.